This can always go lower, you can only hold the carrot out in front so long before the investors stop nibbling. Has the phase II been officially been satisfied, has the PR that has been released posting the the statistical results complete for this study. Or did we just satisfy another hurdle to get us closer to completing phase II. Because if the news comes out that way, we could see this go sub penny sorry to say....This is an OTC highly speculative investment and if this company starts slipping up, the public will loose support for the substance of this project which I believe is solid. They must be accountable if you give out time lines, you had better stick to them. These guys ment well with ADOT, always a good PR then a setback, the o/s went up to 16.6 billion shares before imploding.
I think that if we are told that phase II is 100% complete and has satisfied the needs of the FDA to move forward to phase III, then the investors will come in and buy..Give the start date for phase III and a time line, then....If we get this kind of news, in my opinion either a large bio med company may scoop up shares and buy it out....which would be great for share value...or we go higher on our own....but if the news is anything but good it will show in the "bid" come the the offical release of the their findings.
just my opinions of course,
Thank you and please respond
Sashasees
AI
